For all media queries please contact our Communications Advisor.
New Zealanders could get better access to new and improved vaccines, including some developed in New Zealand, following a merger between industry body Medicines New Zealand and its vaccine counterpart, the Vaccines Industry Association of New Zealand (VIANZ).
A publication recently released by Medicines New Zealand entitled Did You Know? highlights some of the difficulties New Zealand faces with health issues and pharmaceutical funding.
Medicines New Zealand is disappointed that patients will potentially miss out on a new medicine for a rare blood disorder known as PNH.
On Tuesday the Australian Government committed AU$691 million Dollars ($832 million NZ) over 5 years for new pharmaceutical investments - a forecast growth of 4.9%.
Dr Sally Eyers has won this year's Medicines New Zealand Value of Medicines Award for excellent research that is likely to vastly improve the safe use of a commonly used medicine.